» Articles » PMID: 35312280

Single-Molecule Sensor for High-Confidence Detection of MiRNA

Overview
Journal ACS Sens
Specialty Biotechnology
Date 2022 Mar 21
PMID 35312280
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) play a crucial role in regulating gene expression and have been linked to many diseases. Therefore, sensitive and accurate detection of disease-linked miRNAs is vital to the emerging revolution in early diagnosis of diseases. While the detection of miRNAs is a challenge due to their intrinsic properties such as small size, high sequence similarity among miRNAs and low abundance in biological fluids, the majority of miRNA-detection strategies involve either target/signal amplification or involve complex sensing designs. In this study, we have developed and tested a DNA-based fluorescence resonance energy transfer (FRET) sensor that enables ultrasensitive detection of a miRNA biomarker (miRNA-342-3p) expressed by triple-negative breast cancer (TNBC) cells. The sensor shows a relatively low FRET state in the absence of a target but it undergoes continuous FRET transitions between low- and high-FRET states in the presence of the target. The sensor is highly specific, has a detection limit down to low femtomolar (fM) without having to amplify the target, and has a large dynamic range (3 orders of magnitude) extending to 300 000 fM. Using this strategy, we demonstrated that the sensor allows detection of miRNA-342-3p in the miRNA-extracts from cancer cell lines and TNBC patient-derived xenografts. Given the simple-to-design hybridization-based detection, the sensing platform developed here can be used to detect a wide range of miRNAs enabling early diagnosis and screening of other genetic disorders.

Citing Articles

The deleted in oral cancer (DOC1 aka CDK2AP1) tumor suppressor gene is downregulated in oral squamous cell carcinoma by multiple microRNAs.

Stabile R, Cabezas M, Verhagen M, Tucci F, van den Bosch T, De Herdt M Cell Death Dis. 2023; 14(5):337.

PMID: 37217493 PMC: 10202934. DOI: 10.1038/s41419-023-05857-2.


microRNA Detection via Nanostructured Biochips for Early Cancer Diagnostics.

Martino S, Tammaro C, Misso G, Falco M, Scrima M, Bocchetti M Int J Mol Sci. 2023; 24(9).

PMID: 37175469 PMC: 10178165. DOI: 10.3390/ijms24097762.


Rapid Detection of Ag(I) via Size-Induced Photoluminescence Quenching of Biocompatible Green-Emitting, l-Tryptophan-Scaffolded Copper Nanoclusters.

Aarya , Thomas T, Sarangi B, Sen Mojumdar S ACS Omega. 2023; 8(16):14630-14640.

PMID: 37125097 PMC: 10134478. DOI: 10.1021/acsomega.3c00462.


Iron Oxide Nanoparticles: A Review on the Province of Its Compounds, Properties and Biological Applications.

Ramasami Sundhar Baabu P, Kumar H, Gumpu M, Babu K J, Kulandaisamy A, Rayappan J Materials (Basel). 2023; 16(1).

PMID: 36614400 PMC: 9820855. DOI: 10.3390/ma16010059.


Ratiometric Fluorescence Detection of Colorectal Cancer-Associated Exosomal miR-92a-3p with DSN-Assisted Signal Amplification by a MWCNTs@Au NCs Nanoplatform.

Sun Z, Li J, Tong Y, Zhao L, Zhou X, Li H Biosensors (Basel). 2022; 12(7).

PMID: 35884336 PMC: 9312788. DOI: 10.3390/bios12070533.

References
1.
Chang Y, Kuo W, Hung J, Lee C, Lee Y, Chang Y . Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing. Mol Cancer. 2015; 14:36. PMC: 4351690. DOI: 10.1186/s12943-015-0301-9. View

2.
Rashid N, Hairr N, Murray G, Olex A, Leftwich T, Grible J . Identification of nuclear export inhibitor-based combination therapies in preclinical models of triple-negative breast cancer. Transl Oncol. 2021; 14(12):101235. PMC: 8512760. DOI: 10.1016/j.tranon.2021.101235. View

3.
Damaskos C, Garmpi A, Nikolettos K, Vavourakis M, Diamantis E, Patsouras A . Triple-Negative Breast Cancer: The Progress of Targeted Therapies and Future Tendencies. Anticancer Res. 2019; 39(10):5285-5296. DOI: 10.21873/anticanres.13722. View

4.
Leach J, Wang A, Ye K, Jin S . A RNA-DNA Hybrid Aptamer for Nanoparticle-Based Prostate Tumor Targeted Drug Delivery. Int J Mol Sci. 2016; 17(3):380. PMC: 4813238. DOI: 10.3390/ijms17030380. View

5.
Harrell J, Pfefferle A, Zalles N, Prat A, Fan C, Khramtsov A . Endothelial-like properties of claudin-low breast cancer cells promote tumor vascular permeability and metastasis. Clin Exp Metastasis. 2013; 31(1):33-45. PMC: 3892109. DOI: 10.1007/s10585-013-9607-4. View